Dermata Therapeutics (DRMA) Institutional Ownership → See this before next week's Fed meeting (From Stansberry Research) (Ad) Free DRMA Stock Alerts $0.33 -0.02 (-6.95%) (As of 10:48 AM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Dermata Therapeutics (NASDAQ:DRMA)CurrentInstitutional OwnershipPercentage8.67%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$299.23KNumber ofInstitutional Sellers(last 12 months)0 Get DRMA Insider Trade Alerts Want to know when executives and insiders are buying or selling Dermata Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DRMA Institutional Buying and Selling by Quarter Ad Chaikin Analytics“The Biggest Bubble of All Time” – Here’s What to Do.Despite AI's incredible run-up in 2023, we're getting some conflicting messages. Analysts at JP Morgan warn that an "AI-driven bubble" could drag the entire stock market down. Folks at Morgan Stanley say AI hysteria is creating conditions like the dot-com collapse. Even AI leaders (the people who benefit the most!) are getting worried.Just click here. Dermata Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Armistice Capital LLC218,000$133K0.0%N/A6.158% 11/13/2023Acadian Asset Management LLC75,538$79K0.0%+34.2%2.368% 8/7/2023Acadian Asset Management LLC56,285$92K0.0%N/A2.405% 7/27/2023Virtu Financial LLC32,105$53K0.0%N/A1.372% 11/7/2022Virtu Financial LLC70,808$37K0.0%N/A0.701% (Data available from 1/1/2016 forward) DRMA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DRMA shares? During the previous two years, the following institutional investors and hedge funds held shares of Dermata Therapeutics shares: Armistice Capital LLC ($133K), and Acadian Asset Management LLC ($79K), Virtu Financial LLC ($53K).Learn more on DRMA's institutional investors. What percentage of Dermata Therapeutics stock is owned by institutional investors? 8.67% of Dermata Therapeutics stock is owned by institutional investors. Learn more on DRMA's institutional investor holdings. Which institutional investors have been buying Dermata Therapeutics stock? The following institutional investors have purchased Dermata Therapeutics stock in the last 24 months: Armistice Capital LLC ($218K), Virtu Financial LLC ($102.91K), and Acadian Asset Management LLC ($75.54K). How much institutional buying is happening at Dermata Therapeutics? Institutional investors have bought a total of 396,451 shares in the last 24 months. This purchase volume represents approximately $888.47K in transactions. Related Companies: PBLA Institutional Ownership INM Institutional Ownership QLGN Institutional Ownership GLMD Institutional Ownership LSDI Institutional Ownership GRI Institutional Ownership BPTH Institutional Ownership CMND Institutional Ownership NBSE Institutional Ownership SLRX Institutional Ownership This page (NASDAQ:DRMA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap Profits“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin Analyticstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWill this $2 AI stock double overnight?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
